Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Article in English | MEDLINE | ID: mdl-25726172

ABSTRACT

Forskolin, a diterpene, 7ß-acetoxy-8,13-epoxy-1α,6ß,9α-trihydroxy-labd-14-en-11-one (C22H34O7) isolated from Coleus forskohlii, exerts multiple physiological effects by stimulating the enzyme adenylate cyclase and increasing cyclic adenosine monophosphate (cAMP) concentrations. Forskolin is used in the treatment of hypertension, congestive heart failure, eczema, and other diseases. A cytogenetic assay was performed in Allium cepa to assess possible genotoxic effects of forskolin. Forskolin was tested at concentrations 5-100 µM for exposure periods of 24 or 48 h. Treated samples showed significant reductions in mitotic index (p < 0.05) and increases in the frequency of chromosome aberrations (p < 0.01) at both exposure times. The treated meristems showed chromosome aberrations including sticky metaphases, sticky anaphases, laggard, anaphase bridges, micronuclei, polyploidy, fragments, breaks, and C-mitosis. Forskolin may cause genotoxic effects and further toxicological evaluations should be conducted to ensure its safety.


Subject(s)
Bronchodilator Agents/toxicity , Chromosome Aberrations , Colforsin/toxicity , Meristem/drug effects , Onions/drug effects , Vasodilator Agents/toxicity , Anaphase/drug effects , Bronchodilator Agents/isolation & purification , Coleus/chemistry , Colforsin/isolation & purification , Humans , Meristem/cytology , Meristem/genetics , Metaphase/drug effects , Micronuclei, Chromosome-Defective , Mutagenicity Tests , Onions/cytology , Onions/genetics , Polyploidy , Vasodilator Agents/isolation & purification
2.
PLoS One ; 8(6): e67098, 2013.
Article in English | MEDLINE | ID: mdl-23826202

ABSTRACT

Abdominal aortic aneurysm (AAA) is a common chronic degenerative disease characterized by progressive aortic dilation and rupture. The mechanisms underlying the role of α-tocopherol and ß-carotene on AAA have not been comprehensively assessed. We investigated if α-tocopherol and ß-carotene supplementation could attenuate AAA, and studied the underlying mechanisms utilized by the antioxidants to alleviate AAA. Four-months-old Apoe(-/-) mice were used in the induction of aneurysm by infusion of angiotensin II (Ang II), and were orally administered with α-tocopherol and ß-carotene enriched diet for 60 days. Significant increase of LDL, cholesterol, triglycerides and circulating inflammatory cells was observed in the Ang II-treated animals, and gene expression studies showed that ICAM-1, VCAM-1, MCP-1, M-CSF, MMP-2, MMP-9 and MMP-12 were upregulated in the aorta of aneurysm-induced mice. Extensive plaques, aneurysm and diffusion of inflammatory cells into the tunica intima were also noticed. The size of aorta was significantly (P = 0.0002) increased (2.24±0.20 mm) in the aneurysm-induced animals as compared to control mice (1.17±0.06 mm). Interestingly, ß-carotene dramatically controlled the diffusion of macrophages into the aortic tunica intima, and circulation. It also dissolved the formation of atheromatous plaque. Further, ß-carotene significantly decreased the aortic diameter (1.33±0.12 mm) in the aneurysm-induced mice (ß-carotene, P = 0.0002). It also downregulated ICAM-1, VCAM-1, MCP-1, M-CSF, MMP-2, MMP-9, MMP-12, PPAR-α and PPAR-γ following treatment. Hence, dietary supplementation of ß-carotene may have a protective function against Ang II-induced AAA by ameliorating macrophage recruitment in Apoe(-/-) mice.


Subject(s)
Aortic Aneurysm, Abdominal/diet therapy , Apolipoproteins E/deficiency , Dietary Supplements , Macrophages/metabolism , alpha-Tocopherol/administration & dosage , beta Carotene/administration & dosage , Angiotensin II , Animals , Antioxidants/administration & dosage , Aorta, Abdominal/immunology , Aorta, Abdominal/pathology , Aortic Aneurysm, Abdominal/immunology , Aortic Aneurysm, Abdominal/pathology , Apolipoproteins E/genetics , Cholesterol, LDL/metabolism , Disease Models, Animal , Lymphocytes/metabolism , Lymphocytes/pathology , Macrophages/pathology , Male , Mice, Knockout , Organ Size , Plaque, Atherosclerotic/diet therapy , Plaque, Atherosclerotic/immunology , Plaque, Atherosclerotic/pathology
3.
Toxicol In Vitro ; 27(1): 438-40, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22921987

ABSTRACT

Vitiligo is an acquired depigmentation disorder affecting 0.1% to >8.8% in Indian population. Psoralen and ultraviolet A radiation (PUVA) is a gold standard treatment for vitiligo, however, response is still empirical. In order to investigate whether drug response variation is influenced by the repair ability of PUVA treated vitiligo subjects, single cell gel electrophoresis (SCGE) for genotoxicity and serum malonaldehyde (MDA) for cytotoxicity were performed on 107 subjects (77 cases and 30 healthy controls) in South Indian population. In vitro repair ability was assessed by considering the residual damage. A significant difference was observed between the patients and controls with regard to their mean values of DNA damage and MDA levels (p<0.05). On categorization to fast and slow responders based on the time of response, patients exhibited a significant deviation in residual DNA damage, suggestive of variation with respect to DNA repair efficiency (p<0.05). This is the first study to our knowledge with respect to PUVA drug response variation in vitiligo in relation to DNA repair. Large systematic studies on DNA repair may help in a better understanding of the mechanisms involved in the PUVA drug response variation.


Subject(s)
DNA Repair , PUVA Therapy , Vitiligo/drug therapy , Adolescent , Adult , Comet Assay , DNA Damage , Female , Humans , Male , Malondialdehyde/blood , Vitiligo/blood , Vitiligo/genetics , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL